OncoFusion
|
3
|
Zenith Epigenetics
|
Jul 20, 2017 01:12PM
|
Re: And volume shoots up again...281K traded
|
3
|
Resverlogix Corp.
|
Dec 09, 2019 03:12PM
|
Re: PNH Trial?
|
3
|
Resverlogix Corp.
|
Jul 05, 2017 05:35PM
|
Re: I'm Weary of Articles that Reference....
|
3
|
Resverlogix Corp.
|
Mar 13, 2019 01:42PM
|
Re: Stockhouse posters.....
|
3
|
Resverlogix Corp.
|
Sep 07, 2018 10:23AM
|
Re: Lobbying Firm and Resverlogix
|
3
|
Resverlogix Corp.
|
Jul 14, 2017 05:42PM
|
Re: Zenith new VP
|
3
|
Zenith Epigenetics
|
Jul 30, 2017 08:49AM
|
Re: Next Hurdle
|
3
|
Resverlogix Corp.
|
Jan 05, 2018 01:14PM
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Feb 28, 2019 02:56PM
|
Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19 Clinical Trial
|
3
|
Resverlogix Corp.
|
Oct 12, 2021 06:37PM
|
Re: 250 MACE scenario question
|
3
|
Resverlogix Corp.
|
Jan 23, 2019 05:24PM
|
Re: Interesting Trades / Volume .....
|
3
|
Resverlogix Corp.
|
Jan 26, 2019 09:19PM
|
Re: Alkaline Phosphatase
|
3
|
Resverlogix Corp.
|
Feb 22, 2019 08:35AM
|
Re: The Phase 1 trail CKD in New Zealand
|
3
|
Resverlogix Corp.
|
Apr 02, 2019 12:55PM
|
Re: Debt and 28 August
|
3
|
Resverlogix Corp.
|
Jul 28, 2017 10:51AM
|
Slides are up
|
3
|
Resverlogix Corp.
|
Oct 17, 2017 12:12PM
|
Re: Fear Uncertainty and Doubt...Is it all based on the PPS?
|
3
|
Resverlogix Corp.
|
Jun 05, 2018 04:07PM
|
ZEN003694 Trial is now recruiting patients
|
3
|
Zenith Epigenetics
|
Apr 13, 2016 01:14PM
|
The Faces of Cardiovascular Disease
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 02:46PM
|
Re: And volume shoots up again...281K traded
|
3
|
Resverlogix Corp.
|
Dec 09, 2019 03:58PM
|